Cargando…

Correction: Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies

Detalles Bibliográficos
Autores principales:	Draborg, Anette H., Lydolph, Magnus C., Westergaard, Marie, Olesen Larsen, Severin, Nielsen, Christoffer T., Duus, Karen, Jacobsen, Søren, Houen, Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726546/ https://www.ncbi.nlm.nih.gov/pubmed/26808424 http://dx.doi.org/10.1371/journal.pone.0148151

Ejemplares similares

Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies
por: Draborg, Anette H., et al.
Publicado: (2015)

Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients
por: Draborg, Anette Holck, et al.
Publicado: (2014)

Epstein-Barr Virus and Systemic Lupus Erythematosus
por: Draborg, Anette Holck, et al.
Publicado: (2012)

Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients
por: Draborg, Anette Holck, et al.
Publicado: (2016)

Epstein-Barr Virus in Systemic Autoimmune Diseases
por: Draborg, Anette Holck, et al.
Publicado: (2013)

Isotypes of Epstein-Barr Virus Antibodies in Rheumatoid Arthritis: Association with Rheumatoid Factors and Citrulline-Dependent Antibodies
por: Westergaard, Marie Wulff, et al.
Publicado: (2015)

Elevated Antibody Titers to Epstein–Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus
por: Knudsen, Julie, et al.
Publicado: (2023)

EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls
por: Trier, Nicole Hartwig, et al.
Publicado: (2019)

Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study
por: Svendsen, Anders J., et al.
Publicado: (2021)

Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status
por: Draborg, Anette Holck, et al.
Publicado: (2018)

Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients
por: Rasmussen, NS, et al.
Publicado: (2015)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis
por: Trier, Nicole Hartwig, et al.
Publicado: (2018)

Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus
por: Jog, Neelakshi R., et al.
Publicado: (2021)

Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus
por: Chen, Xiaotong, et al.
Publicado: (2023)

Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional Study
por: Piroozmand, Ahmad, et al.
Publicado: (2017)

Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands—Relation to Rheumatoid Arthritis
por: Trier, Nicole, et al.
Publicado: (2018)

Reactivity of Rheumatoid Arthritis-Associated Citrulline-Dependent Antibodies to Epstein-Barr Virus Nuclear Antigen1-3
por: Fanelli, Ilaria, et al.
Publicado: (2022)

Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood
por: Moon, Uk Yeol, et al.
Publicado: (2004)

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
por: Lossius, Andreas, et al.
Publicado: (2012)

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals
por: Jog, Neelakshi R., et al.
Publicado: (2019)

Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions
por: Buonavoglia, Alessio, et al.
Publicado: (2021)

Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

Aluminum Hydroxide Adjuvant Differentially Activates the Three Complement Pathways with Major Involvement of the Alternative Pathway
por: Güven, Esin, et al.
Publicado: (2013)

Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus
por: Wood, Rebecca A., et al.
Publicado: (2021)

Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
por: Nagata, Keiko, et al.
Publicado: (2020)

Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus
por: Larsen, Martin, et al.
Publicado: (2011)

Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017)

Epstein–Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement
por: Miskovic, Rada, et al.
Publicado: (2023)

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus
por: Hanlon, Peter, et al.
Publicado: (2014)

The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysis
por: Li, Zhao-Xia, et al.
Publicado: (2018)

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
por: Munroe, Melissa E., et al.
Publicado: (2021)

Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
por: Chen, Ruyue, et al.
Publicado: (2023)

Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus
por: Østergaard, Ole, et al.
Publicado: (2017)

Is There Diagnostic Value in Detection of Immunoglobulin G Antibodies to the Epstein–Barr Virus Early Antigen?
por: Crowley, Andrea, et al.
Publicado: (2012)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus
por: Nielsen, Christoffer T, et al.
Publicado: (2014)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Lymphocytic Interstitial Pneumonitis Associated with Epstein-Barr virus in Systemic Lupus Erythematosus and Sjögren’s Syndrome.: Complete remission with corticosteroid and cyclophosphamide
por: Yum, Ho-Kee, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_r4nj8n61cun6o4n6ea3uv3fb0d